Anew Era TMS & Psychiatry - Huntington Beach
7677 Center Avenue, 405, Huntington Beach
4.7(104 Google reviews)
United States
3 listed treatment centers serving Huntington Beach and the surrounding area.
7677 Center Avenue, 405, Huntington Beach
4.7(104 Google reviews)
1501 Superior Avenue, Suite 210, Newport Beach
4.9(81 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Huntington Beach.
8.2 miles away · Irvine
8.2 miles away · Irvine
8.4 miles away · Irvine
9.5 miles away · Irvine
9.8 miles away · Santa Ana
10.2 miles away · Irvine
3 Corporate Park, 170, Irvine
4.5(129 Google reviews)
For people in Huntington Beach, the cost of Spravato depends on the insurance plan, treatment setting, and prescribed schedule. Ask about the full visit—not just the nasal spray. The medication and the observed treatment and monitoring services may be billed separately, so a medication benefit alone does not tell you your total financial responsibility.
Prior authorization and documentation of earlier antidepressant trials are common requirements. A treatment center may need records showing which medicines you tried and how you responded. Ask which records are needed, who will request authorization, and whether approval includes both the medicine and the monitored visits. Authorization is not a guarantee that every charge will be paid.
Medicare coverage may fall under Part B or Part D depending on the plan and setting. California Medicaid coverage also depends on the applicable plan and treatment setting. Do not assume that a directory listing means a center accepts either program; confirm directly with the center and your insurer.
Manufacturer savings programs exist for eligible commercially insured patients, but they are not for patients using government insurance. Ask about current eligibility rules and which expenses a program may help with.
Before starting, ask the center and insurer:
Include transportation and time away from work in your planning, too.
Spravato is not a take-home nasal spray. Patients administer it themselves under direct observation at a healthcare setting certified through the Spravato REMS program. A directory listing that says a location offers treatment does not, by itself, confirm current REMS certification. Check that status with the center before making arrangements.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance visits may then be weekly or every two weeks. Your prescriber will individualize the schedule; do not assume that a particular frequency is guaranteed.
Plan for at least two hours of monitoring after each dose, plus any time needed for check-in, assessment, and administration. Ask the center how much time to reserve rather than treating two hours as a guaranteed departure time. Discuss recurring appointments and time off with your employer if needed, while sharing only the medical information you are comfortable disclosing.
You need someone else to drive you home after every treatment. You must not drive or operate machinery until the next day after a restful sleep. Arrange rides before booking, identify a backup driver, and ask whether the center has requirements for escorts or pickup arrangements.
If you cannot find a listed Huntington Beach center, or local appointments are unavailable, you can broaden your directory search to Newport Beach, Irvine, Long Beach, or Anaheim. Listings are also available in Los Angeles. Confirm certification, appointment availability, and insurance participation directly before choosing a location. Consider whether you and your driver can manage repeated trips—not just the first appointment.
Start with Huntington Beach directory listings, then contact the location to confirm that it is currently certified through the Spravato REMS program. The supplied listings do not establish certification status. Ask whether the center is accepting new patients and how its evaluation process works. If local options do not meet your needs, consider listings in Newport Beach, Irvine, Long Beach, or Anaheim.
Spravato is FDA-approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your history and safety considerations; an approved indication does not automatically establish personal eligibility.
Coverage depends on your plan and the treatment setting. Prior authorization and records of previous antidepressant trials are common requirements. Ask your insurer about both the medication and the monitored visit, including network status and your share of costs. Medicare and California Medicaid may cover treatment depending on the plan and setting, but you must separately confirm that the center accepts your coverage.
You self-administer the nasal spray under a healthcare provider’s direct observation at a REMS-certified setting. Staff monitor you for at least two hours after dosing, including for sedation, dissociation, breathing problems, and blood pressure increases. The overall appointment may take longer. Someone else must drive you home, and you cannot drive or operate machinery until the next day after a restful sleep.
Discuss sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Tell the clinician about your health history, medicines, and substance-use concerns so they can assess risks and explain the monitoring plan.
Do not wait for a treatment appointment to seek urgent help. In an emergency, call or text 988 or call 911. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically warranted. Its approval for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior requires use with an oral antidepressant.
Approved uses, nearby treatment centers, and medically sourced patient guides.